Disparities in the management of cutaneous malignant melanoma. A population-based high-resolution study.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 13 12 2018
revised: 18 02 2019
accepted: 25 03 2019
pubmed: 18 4 2019
medline: 21 1 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

Population-based cancer registry data from three Spanish areas were used to assess the patterns of care and adherence to guidelines for cutaneous malignant melanoma. We included 934 cases diagnosed in 2009-2013. Completeness of the pathology reports, imaging for detecting distant metastasis and the use of sentinel lymph node biopsy (SLNB) were analysed. The proportion of pathology reports that mentioned the essential pathological features required for T staging was 93%, ranging across geographic areas from 81% to 98% (p < 0.001). The percentage of low-risk patients who underwent no imaging studies, as proposed by guidelines, or only chest imaging ranged among areas from 0.6% to 84% (p < 0.001). Of the patients with clinically node-negative melanoma >1 mm thick and no distant metastases, 68% underwent SLNB, varying by area from 61% to 78% (p = 0.017). This study revealed wide geographic variation in different aspects of melanoma care. The use of a standardised structured pathology report could strengthen the completeness of reporting. Improvement strategies should also include efforts to reduce overuse of imaging in low-risk patients and to increase the adherence to guidelines recommendations on the use of SLNB.

Identifiants

pubmed: 30993764
doi: 10.1111/ecc.13043
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Pagination

e13043

Subventions

Organisme : Andalusian Department of Health: Research, Development, and Innovation Office
ID : PI-0152/2017
Organisme : La Caixa Foundation

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Marcela Guevara (M)

Navarra Public Health Institute - IdiSNA, Pamplona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Miguel Rodríguez-Barranco (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Andalusian School of Public Health, Biomedical Research Institute of Granada (ibs.Granada), University of Granada, Granada, Spain.

Montse Puigdemont (M)

Epidemiology Unit and Girona Cancer Registry, Descriptive Epidemiology, Genetics and Cancer Prevention Group, IdIbGi, Catalan Institute of Oncology, Girona, Spain.

Pamela Minicozzi (P)

Analytical Epidemiology and Health Impact Unit, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Ignacio Yanguas-Bayona (I)

Dermatology Department, Navarra Hospital Complex - IdiSNA, Pamplona, Spain.

Miguel Porras-Povedano (M)

Área de Gestión Sanitaria de Osuna, Servicio Andaluz de Salud, Sevilla, Spain.

Jordi Rubió-Casadevall (J)

Medical Oncology Department, Catalan Institute of Oncology, Descriptive Epidemiology, Genetics and Cancer Prevention Group, IdIbGi, University of Girona, Girona, Spain.

María José Sánchez Pérez (MJ)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Andalusian School of Public Health, Biomedical Research Institute of Granada (ibs.Granada), University of Granada, Granada, Spain.

Rafael Marcos-Gragera (R)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Epidemiology Unit and Girona Cancer Registry, Descriptive Epidemiology, Genetics and Cancer Prevention Group, IdIbGi, Catalan Institute of Oncology, Girona, Spain.

Eva Ardanaz (E)

Navarra Public Health Institute - IdiSNA, Pamplona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH